Article
Variant-to-Biomarker Integration and Mechanistic Validation Identify CES1 as a Copy Number-Linked Predictor of Radiotherapy Response in Rectal Cancer.
Human mutation - 1 Jan 2026
Yang Xiaodong, Zheng Mingye, Lu Xiaoxia, Li Yongxiang
Abstract excerpt
Background: Radiotherapy is a fundamental component of rectal cancer treatment, yet patient responses remain highly heterogeneous due to the lack of reliable biomarkers supported by genomic variation evidence. Integrating multi-cohort transcriptomic data with machine-learning approaches enables systematic identification of genes with both predictive and therapeutic relevance. This study aimed to develop a robust...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
